Austco Healthcare Ltd (AHC) - Net Assets
Based on the latest financial reports, Austco Healthcare Ltd (AHC) has net assets worth AU$51.73 Million AUD (≈ $36.60 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$91.07 Million ≈ $64.43 Million USD) and total liabilities (AU$39.34 Million ≈ $27.83 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AHC financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$51.73 Million |
| % of Total Assets | 56.8% |
| Annual Growth Rate | 8.86% |
| 5-Year Change | 168.07% |
| 10-Year Change | 325.04% |
| Growth Volatility | 49.44 |
Austco Healthcare Ltd - Net Assets Trend (2005–2025)
This chart illustrates how Austco Healthcare Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Austco Healthcare Ltd asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Austco Healthcare Ltd (2005–2025)
The table below shows the annual net assets of Austco Healthcare Ltd from 2005 to 2025. For live valuation and market cap data, see Austco Healthcare Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$51.73 Million ≈ $36.60 Million |
+16.56% |
| 2024-06-30 | AU$44.38 Million ≈ $31.40 Million |
+77.52% |
| 2023-06-30 | AU$25.00 Million ≈ $17.69 Million |
+8.26% |
| 2022-06-30 | AU$23.09 Million ≈ $16.34 Million |
+19.67% |
| 2021-06-30 | AU$19.30 Million ≈ $13.65 Million |
+18.69% |
| 2020-06-30 | AU$16.26 Million ≈ $11.50 Million |
+54.32% |
| 2019-06-30 | AU$10.54 Million ≈ $7.45 Million |
+9.95% |
| 2018-06-30 | AU$9.58 Million ≈ $6.78 Million |
+15.96% |
| 2017-06-30 | AU$8.26 Million ≈ $5.85 Million |
-32.10% |
| 2016-06-30 | AU$12.17 Million ≈ $8.61 Million |
-21.67% |
| 2015-06-30 | AU$15.54 Million ≈ $10.99 Million |
+8.09% |
| 2014-06-30 | AU$14.37 Million ≈ $10.17 Million |
+35.16% |
| 2013-06-30 | AU$10.63 Million ≈ $7.52 Million |
+12.37% |
| 2012-06-30 | AU$9.46 Million ≈ $6.70 Million |
+40.23% |
| 2011-06-30 | AU$6.75 Million ≈ $4.78 Million |
-59.54% |
| 2010-06-30 | AU$16.68 Million ≈ $11.80 Million |
-37.17% |
| 2009-06-30 | AU$26.55 Million ≈ $18.78 Million |
-25.69% |
| 2008-06-30 | AU$35.72 Million ≈ $25.28 Million |
+1.25% |
| 2007-06-30 | AU$35.28 Million ≈ $24.96 Million |
+183.60% |
| 2006-06-30 | AU$12.44 Million ≈ $8.80 Million |
+31.28% |
| 2005-06-30 | AU$9.48 Million ≈ $6.71 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Austco Healthcare Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 905.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$54.89 Million | 106.11% |
| Other Comprehensive Income | AU$1.27 Million | 2.46% |
| Other Components | AU$1.00 | 0.00% |
| Total Equity | AU$51.73 Million | 100.00% |
Austco Healthcare Ltd Competitors by Market Cap
The table below lists competitors of Austco Healthcare Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aditya Birla Money Limited
NSE:BIRLAMONEY
|
$87.55 Million |
|
Bathurst Resources Ltd
F:B0R
|
$87.56 Million |
|
Knafaim
TA:KNFM
|
$87.58 Million |
|
Winchester Bancorp, Inc. Common Stock
NASDAQ:WSBK
|
$87.61 Million |
|
Brand X Co. Ltd.
KQ:337930
|
$87.48 Million |
|
PVP Ventures Limited
NSE:PVP
|
$87.47 Million |
|
Sanitar Co Ltd
TW:1817
|
$87.43 Million |
|
KNH Enterprise Co Ltd
TW:9919
|
$87.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Austco Healthcare Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 44,378,000 to 51,727,000, a change of 7,349,000 (16.6%).
- Net income of 5,933,000 contributed positively to equity growth.
- Share repurchases of 425,000 reduced equity.
- New share issuances of 425,000 increased equity.
- Other comprehensive income increased equity by 735,999.
- Other factors increased equity by 680,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$5.93 Million | +11.47% |
| Share Repurchases | AU$425.00K | -0.82% |
| Share Issuances | AU$425.00K | +0.82% |
| Other Comprehensive Income | AU$736.00K | +1.42% |
| Other Changes | AU$680.00K | +1.31% |
| Total Change | AU$- | 16.56% |
Book Value vs Market Value Analysis
This analysis compares Austco Healthcare Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.36x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.98x to 2.36x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | AU$0.17 | AU$0.33 | x |
| 2006-06-30 | AU$0.21 | AU$0.33 | x |
| 2007-06-30 | AU$0.44 | AU$0.33 | x |
| 2008-06-30 | AU$0.36 | AU$0.33 | x |
| 2009-06-30 | AU$0.28 | AU$0.33 | x |
| 2010-06-30 | AU$0.18 | AU$0.33 | x |
| 2011-06-30 | AU$0.07 | AU$0.33 | x |
| 2012-06-30 | AU$0.06 | AU$0.33 | x |
| 2013-06-30 | AU$0.06 | AU$0.33 | x |
| 2014-06-30 | AU$0.07 | AU$0.33 | x |
| 2015-06-30 | AU$0.08 | AU$0.33 | x |
| 2016-06-30 | AU$0.06 | AU$0.33 | x |
| 2017-06-30 | AU$0.04 | AU$0.33 | x |
| 2018-06-30 | AU$0.04 | AU$0.33 | x |
| 2019-06-30 | AU$0.04 | AU$0.33 | x |
| 2020-06-30 | AU$0.06 | AU$0.33 | x |
| 2021-06-30 | AU$0.07 | AU$0.33 | x |
| 2022-06-30 | AU$0.08 | AU$0.33 | x |
| 2023-06-30 | AU$0.09 | AU$0.33 | x |
| 2024-06-30 | AU$0.14 | AU$0.33 | x |
| 2025-06-30 | AU$0.14 | AU$0.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Austco Healthcare Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.47%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.29%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 1.76x
- Recent ROE (11.47%) is above the historical average (-8.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 9.28% | 8.74% | 0.87x | 1.22x | AU$-68.70K |
| 2006 | 17.72% | 10.03% | 1.17x | 1.51x | AU$960.90K |
| 2007 | 4.78% | 4.82% | 0.78x | 1.27x | AU$-1.84 Million |
| 2008 | 6.10% | 4.55% | 0.98x | 1.37x | AU$-1.38 Million |
| 2009 | -33.69% | -19.11% | 1.20x | 1.47x | AU$-11.60 Million |
| 2010 | -58.04% | -22.50% | 1.51x | 1.71x | AU$-11.35 Million |
| 2011 | -163.73% | -65.90% | 1.33x | 1.87x | AU$-11.72 Million |
| 2012 | 7.86% | 4.09% | 1.19x | 1.62x | AU$-202.40K |
| 2013 | 9.78% | 4.77% | 1.30x | 1.57x | AU$-23.50K |
| 2014 | 26.89% | 12.35% | 1.47x | 1.48x | AU$2.43 Million |
| 2015 | 7.03% | 3.13% | 1.49x | 1.51x | AU$-460.70K |
| 2016 | -30.00% | -11.40% | 1.46x | 1.81x | AU$-4.87 Million |
| 2017 | -77.66% | -22.15% | 1.67x | 2.10x | AU$-7.24 Million |
| 2018 | 12.46% | 4.12% | 1.72x | 1.75x | AU$235.80K |
| 2019 | 6.05% | 2.01% | 1.61x | 1.87x | AU$-416.50K |
| 2020 | 15.40% | 7.92% | 1.37x | 1.42x | AU$878.20K |
| 2021 | 17.74% | 10.96% | 1.15x | 1.41x | AU$1.49 Million |
| 2022 | 10.08% | 6.49% | 1.05x | 1.47x | AU$18.80K |
| 2023 | 9.03% | 5.38% | 1.11x | 1.51x | AU$-241.90K |
| 2024 | 15.94% | 12.17% | 0.85x | 1.55x | AU$2.64 Million |
| 2025 | 11.47% | 7.29% | 0.89x | 1.76x | AU$760.30K |
Industry Comparison
This section compares Austco Healthcare Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $173,605,821
- Average return on equity (ROE) among peers: -225.35%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Austco Healthcare Ltd (AHC) | AU$51.73 Million | 9.28% | 0.76x | $87.50 Million |
| Ansell Ltd (ANN) | $725.48 Million | -0.58% | 2.19x | $2.63 Billion |
| Nanosonics Ltd (NAN) | $21.71 Million | -26.57% | 0.55x | $697.57 Million |
| Osteopore Ltd (OSX) | $432.60K | -1126.20% | 6.73x | $2.05 Million |
| SDI Ltd (SDI) | $102.67 Million | 11.84% | 0.38x | $103.03 Million |
| Trajan Group Holdings Ltd (TRJ) | $17.74 Million | 14.77% | 1.50x | $40.47 Million |
About Austco Healthcare Ltd
Austco Healthcare Limited, together with its subsidiaries, engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call system; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurs… Read more